(Q33778812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

The pharmacological treatment of urinary incontinence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author

Christopher R Chapple

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

K E Andersson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Appell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L D Cardozo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H P Drutz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A E Finkbeiner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

F Haab

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Vela Navarrete

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

923-947

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571617%20AND%20SRC:MED&resulttype=core&format=json

Current concepts in the treatment of disorders of micturition

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Presence of non-cholinergic motor transmission in human isolated bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Atropine Resistance of Transmurally Stimulated Isolated Human Bladder Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Subtypes of overactive bladder in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A myogenic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A neurologic basis for the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A second look at emepronium bromide in urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Muscarinic receptors--characterization, coupling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Characterization of the functional muscarinic receptors in the rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Value of propantheline bromide in treatment of enuresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Pharmacologic treatment of incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Discovery & development of selective M3 antagonists for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Clinical pharmacology of potassium channel openers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Effects of pinacidil on detrusor instability in men with bladder outlet obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Characterization of the muscarinic cholinoceptors in the human detrusor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The pharmacokinetics of oxybutynin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Oxybutynin in bladder spasm, neurogenic bladder, and enuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Intravesical oxybutynin for spinal cord injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Intravesical oxybutynin chloride: experience with 42 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Low dose oxybutynin for the unstable bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The treatment of the uninhibited bladder with dicyclomine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Brain pertussis toxin-sensitive G proteins are involved in the flavoxate hydrochloride-induced suppression of the micturition reflex in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A review of flavoxate hydrochloride in the treatment of urge incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A Comparison of Emepronium Bromide and Flavoxate Hydrochloride in the Treatment of Urinary Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The effect of noradrenaline on the contractile response of the urinary bladder. An in vitro study in man and cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Prostatic alpha 1-adrenoceptors and uroselectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Effect of β-Adrenoceptor Stimulation on the Human Bladderin vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The effect of beta-adrenoceptor agonists on urinary incontinence in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Double-blind study of imipramine and placebo for incontinence due to bladder instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Drug therapy for nocturnal enuresis. Current treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Hyponatremia in patients with nocturnal enuresis treated with DDAVP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A Double-blind Crossover Trial of Baclofen-a New Treatment for the Unstable Bladder Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The vanilloid (capsaicin) receptor: receptor types and species differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Intravesical capsaicin for neurogenic bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The pathophysiology of stress urinary incontinence in women and its implications for surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Ephedrine in treatment of urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Apha-Adrenergic Agents in Urinary Disorders of the Proximal Urethra Part I. Sphincteric Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

The Effects of Long-Term Treatment with Norephedrine on Stress Incontinence and Urethral Closure Pressure Profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Rabbit as a model of urinary bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Changes in urethral cytology following estrogen administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Effects of estrogen on urethral function in women with urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

A Partially Successful Attempt at Medical Treatment of Urinary-Stress Incontinence in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X

Estrogen and urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.1999.00397.X